Proton Pump Inhibitors (PPIs) Market is Anticipated to Grow at an Impressive CAGR

Stratview Research delivers key insights on the global Proton Pump Inhibitors (PPIs) Market. According to Stratview Research, the market is segmented By Drug Type (Over-the-counter Drugs [Omeprazole, Lansoprazole, Esomeprazole, Others], Prescription Drugs [Rabeprazole, Dexlansoprazole, Pantoprazole, Others]), By Disease (Ulcers, Gastroesophageal Reflux Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Region.

The report also covers the Covid impact on the market. Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and an uptrend is witnessed from 2021.

Market Insights

The report suggests that the overall The Global Proton Pump Inhibitors (PPIs) Market is projected to grow from USD 2.85 billion in 2020 to USD 3.76 billion by 2026 at a CAGR of over 4.7% during the forecast period. The Market report provides critical insights on the market size, share, trend, forecasts, and opportunity analysis.

Market Segments' Analysis

Based on drug type, the global proton pump inhibitors market has been bifurcated into over-the-counter drugs and prescription drugs. The over-the-counter drugs segment is further categorized into omeprazole, lansoprazole, esomeprazole, and others. Among these, the esomeprazole under the OTC drug segment garnered the highest market share in 2020 and is likely to grow at a healthy CAGR during the forecast timeline. Esomeprazole is mainly indicated to treat the symptoms of heartburn, Gastroesophageal Reflux Disease (GERD), and other disorders such as excessive stomach acids, thus bolstering the segment growth.

By region, the North American market accounted for the largest market share in 2020 and is estimated to grow at a steady CAGR during the assessment period. This can be attributed to increasing approvals of proton pump inhibitor products and the increasing prevalence of GERD in the US, Canada, and Mexico, which proliferates the industry growth in the region. Moreover, GERD affects almost 20% of adults in the US, thereby making the disease an important concern, which propels regional growth.

Key Players

The following are some of the key players in the Proton Pump Inhibitors (PPIs) Market:

• AstraZeneca PLC/AB (UK),
• Bayer AG (Germany),
• Pfizer Inc. (The U.S),
• Cadila Pharmaceuticals Limited (India),
• Eisai Pharmaceuticals India Pvt. Ltd (India),
• Santarus, Inc. (The U.S),
• Wyeth, LLC (The U.S),
• Janssen Pharmaceutical (Belgium),
• Takeda Pharmaceutical Company Limited (Japan), and
• Sanofi S.A. (France).

Get a free sample report here: https://www.stratviewresearch.com/Request-Sample/1660/proton-pump-inhibitors-(PPIs)-market.html#form

About Us –

Stratview Research is a leading global market research firm providing expert research solutions, trusted by clients worldwide. To keep our clients ahead of the curve, we provide data backed by extensive market research and in-depth industry knowledge. The broad spectrum of integrated insights is referred to, and cited by press releases, interview with key players, white papers, journals, etc. Stratview research also offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please connect with our team.

Get in touch with us for more details –

Call: +1-313-307-4176 Or Mail Us:  sales@stratviewresearch.com

Article source: https://article-realm.com/article/Business/52178-Proton-Pump-Inhibitors-PPIs-Market-is-Anticipated-to-Grow-at-an-Impressive-CAGR.html